Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

546 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
Pietri E, Andreis D, Fabbri F, Menna C, Schirone A, Kopf B, Rocca A, Amadori D, De Giorgi U. Pietri E, et al. Among authors: de giorgi u. Oncologist. 2015 Mar;20(3):239-40. doi: 10.1634/theoncologist.2014-0326. Epub 2015 Jan 30. Oncologist. 2015. PMID: 25637379 Free PMC article. Clinical Trial.
Prevention and therapy of neutropenia in elderly patients.
Rosti G, Kopf B, Cariello A, Monti M, Dazzi C, Papiani G, Giovanis P, De Giorgi U, Marangolo M. Rosti G, et al. Among authors: de giorgi u. Crit Rev Oncol Hematol. 2003 Jun;46(3):247-53. doi: 10.1016/s1040-8428(03)00024-6. Crit Rev Oncol Hematol. 2003. PMID: 12791424 Review.
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
De Giorgi U, Giannini M, Frassineti L, Kopf B, Palazzi S, Giovannini N, Zumaglini F, Rosti G, Emiliani E, Marangolo M. De Giorgi U, et al. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1165-9. doi: 10.1016/j.ijrobp.2006.02.018. Epub 2006 May 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16682141 Clinical Trial.
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.
Kopf B, De Giorgi U, Vertogen B, Monti G, Molinari A, Turci D, Dazzi C, Leoni M, Tienghi A, Cariello A, Argnani M, Frassineti L, Scarpi E, Rosti G, Marangolo M. Kopf B, et al. Among authors: de giorgi u. Bone Marrow Transplant. 2006 Sep;38(6):407-12. doi: 10.1038/sj.bmt.1705465. Bone Marrow Transplant. 2006. PMID: 16951690 Clinical Trial.
High-dose chemotherapy for triple negative breast cancer.
De Giorgi U, Rosti G, Frassineti L, Kopf B, Giovannini N, Zumaglini F, Marangolo M. De Giorgi U, et al. Ann Oncol. 2007 Jan;18(1):202-203. doi: 10.1093/annonc/mdl306. Epub 2006 Sep 13. Ann Oncol. 2007. PMID: 16971660 Free article. Clinical Trial. No abstract available.
High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party.
De Giorgi U, Blaise D, Lange A, Viens P, Marangolo M, Madroszyk A, Brune M, Afanassiev BV, Rosti G, Demirer T. De Giorgi U, et al. Bone Marrow Transplant. 2007 Dec;40(11):1045-8. doi: 10.1038/sj.bmt.1705880. Epub 2007 Oct 8. Bone Marrow Transplant. 2007. PMID: 17922037
546 results